ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Imaging"

  • Abstract Number: 1328 • ACR Convergence 2022

    CT Evaluation of Bone Fragility 2 Years After Bariatric Surgery in Patients with Obesity: An Observational Study

    Marine FAUNY1, Marion Halin2, Edem Allado2, Didier Quilliot2, Laurent Brunaud2, Eliane Albuisson2, Isabelle Chary-Valckenaere2 and Damien Loeuille2, 1Nancy University Hospital, Toul, France, 2Nancy University Hospital, Vandoeuvre, France

    Background/Purpose: The objectives were to evaluate bone fragility on computed tomography (CT) in patients with obesity before and 2 years after bariatric surgery and to…
  • Abstract Number: 1802 • ACR Convergence 2022

    The Utility of Dual-energy Computed Tomography in Gout Patients During Urate Lowering Therapy

    Min Jung Kim1, Mi Hyeon Kim2, SE RIM CHOI2, Youjin Jung2, Ji In Jung2, Ju Yeon Kim2, Jee Won Chai3 and Kichul Shin4, 1Seoul Metropolitan Government Boramae Medical center, Dongjak-gu, Seoul, Republic of Korea, 2Seoul National University Hospital, Seoul, Republic of Korea, 3Seoul Metropolitan Government–Seoul National University Boramae Medical Center, Seoul, Republic of Korea, 4Seoul Metropolitan Government- Seoul National University Boramae Medical Center, Seoul, Republic of Korea

    Background/Purpose: To investigate whether monosodium urate (MSU) deposition measured by dual-energy computed tomography (DECT) could help predict acute flares after discontinuing colchicine prophylaxis in patients…
  • Abstract Number: 0480 • ACR Convergence 2022

    Treatment of Giant Cell Arteritis Patients with Ultra-short Glucocorticoids and Tocilizumab: Role of Imaging in a Prospective Study

    Francesco Muratore1, Giulia Cassone2, Chiara Marvisi3, ELENA GALLI1, Luigi Boiardi1, GIULIA BESUTTI1, Lucia Spaggiari1, MASSIMILIANO CASALI1, Pamela Mancuso1, Annibale Versari1, Paolo Giorgi Rossi1 and Carlo Salvarani4, 1Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy, 2Università di Modena e Reggio Emilia, Modena, Italy, 3Università di Modena e Reggio Emilia and National Institute of Arthritis & Musculoskeletal & Skin Diseases, National Institutes of Health, Bethesda, MD, 4Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Università di Modena e Reggio Emilia, Reggio Emilia, Italy

    Background/Purpose: To evaluate the clinical and functional/morphological imaging response in a series of active large vessel (LV)-GCA patients treated with tocilizumab (TCZ) monotherapy after ultra-short-term…
  • Abstract Number: 1245 • ACR Convergence 2022

    Imaging Use and Medication Management in Giant Cell Arteritis

    Aradhna Agarwal1, Reid Weisberg1, Jiby Mathew2, Andreas Reimold3 and Kyawt Shwin1, 1UT Southwestern, Dallas, TX, 2VA North Texas Health Care System/Dallas VA Medical Center, Dallas, TX, 3University of Texas Southwestern Medical Center, Dallas, TX

    Background/Purpose: Giant cell arteritis (GCA) affects medium and large arteries. Although temporal artery biopsy (TAB) remains the gold standard for patients with cranial GCA, patients…
  • Abstract Number: 1329 • ACR Convergence 2022

    Prevalence of Bone Fragility on DXA and CT in Patients with Obesity

    Marion Halin1, Edem Allado1, Didier Quilliot1, Eliane Albuisson1, Isabelle Chary-Valckenaere1, Damien Loeuille1, Laurent Brunaud1 and Marine FAUNY2, 1Nancy University Hospital, Vandoeuvre, France, 2Nancy University Hospital, Toul, France

    Background/Purpose: Primary objective was to evaluate bone fragility prevalence on dual X-ray absorptiometry (DXA) and on computed tomography (CT), in patients with severe obesity. Secondary…
  • Abstract Number: 1816 • ACR Convergence 2022

    Assessing Urate Deposition and Inflammation in the Vasculature of Gout Patients Using Dual Energy Computed Tomography and Positron Emission Tomography Pre and Post Pegloticase- a Pilot Study

    Ira Khanna, Venkatesh Mani, Renata Pyzik, Audrey Kaufman, Wei Wei Chi, Emilia Bagiella, Philip Robson and Yousaf Ali, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Gout is the most common inflammatory arthritis, caused by hyperuricemia and subsequent deposition of aggregated monosodium urate (MSU) crystals in both articular and extra-articular…
  • Abstract Number: 0166 • ACR Convergence 2021

    Digital Extensor Paratenonitis Is Frequent in Early Rheumatoid Arthritis

    Mihaela Maruseac1, Adrien NZEUSSEU TOUKAP2 and Maria S. Stoenoiu3, 1Rheumatology department, Cliniques Universitaires Saint-Luc, Brussel, Belgium, 2Rheumatology department, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium, 3Rheumatology department, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium

    Background/Purpose: Finger extensor tendon involvement (FEP) or paratenonitis has previously been described by ultrasound (US) in patients suffering from early psoriatic arthritis. Contradictory results were…
  • Abstract Number: 0503 • ACR Convergence 2021

    18F-fluorodeoxyglucose Positron Emission Tomography as a Predictor of Angiographic Progression of Disease in Large-vessel Vasculitis

    Kaitlin Quinn1, Mark A. Ahlman2, Hugh Alessi3, Ashkan Malayeri2, Jamie Marko2, Elaine Novakovich2 and Peter Grayson4, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Washington, DC, 2National Institutes of Health, Bethesda, MD, 3National Institutes of Health, Bethesda, Maryland, 4National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD

    Background/Purpose: There is limited prospective data characterizing arterial lesions over time in giant cell arteritis (GCA) and Takayasu’s arteritis (TAK), the two main forms of…
  • Abstract Number: 1414 • ACR Convergence 2021

    The Current State of Expedited Referral Systems Incorporating Vasculitis Ultrasound for the Diagnosis of Giant Cell Arteritis in Rheumatology Practices in the United States

    Mark Matza1, Karina Torralba2 and Minna Kohler3, 1Massachusetts General Hospital, Boston, MA, 2Division of Rheumatology, Department of Medicine, Loma Linda University Healthcare, Loma Linda, CA, 3Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Expedited referral systems or “fast-track” clinics incorporating vasculitis ultrasound (VUS) into the evaluation of patients with suspected giant cell arteritis (GCA) have shown reduced…
  • Abstract Number: 0167 • ACR Convergence 2021

    Reliability of a Novel Pediatric Joint-Specific Scoring System for the Elbow, Wrist and Finger Joints

    Patricia Vega-Fernandez1, Ysabella Esteban2, Edward Oberle3, Jean-Philippe Proulx-Gauthier4, Matthew Clark5, Hulya Bukulmez6, Susan Shenoi7, Akaluck Thatayatikom8, Heather Benham9, Emily Brunner10, Leandra Woolnough8, Michael Henrickson1, Laura Ballenger3, Deidre DeRanieri11, Sarah Hoffmann12, Ginger Janow13, Mekibib Altaye14, Amy Cassedy2, Johannes Roth15 and Tracy Ting1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, 3Nationwide Children's Hospital, Columbus, OH, 4CHU de Quebec - Universite Laval, Québec City, QC, Canada, 5Vanderbilt University Medical Center, Nashville, TN, 6MetroHealth Medical Center, Case Western Reserve, Pepper Pike, OH, 7Seattle Children's Hospital, Seattle, WA, 8University of Florida, Gainesville, FL, 9Scottish RIte Hospital, North Richland Hills, TX, 10Geisinger, Bloomsburg, PA, 11Lurie Children's Hospital, Chicago, IL, 12Children's Hospital of Richmond at VCU, Richmond, VA, 13Joseph M. Sanzari Children's Hospital at Hackensack Meridian Health, Glen Rock, NJ, 14Cincinnati Children's Hospital, Cincinnati, OH, 15University of Ottawa, Ottawa, ON, Canada

    Background/Purpose: The clinical decision-making process in pediatric arthritis lacks an objective, reliable bedside imaging tool. Musculoskeletal ultrasound (MSUS) is increasingly being utilized in children. In…
  • Abstract Number: 0703 • ACR Convergence 2021

    CD8 Positron Emission Tomography (PET/CT) Imaging with 89Zr-Df-IAB22M2C in Patients with Inclusion Body Myositis

    Colin Quinn1, Kelsey Moulton1, Ron Korn2, William Le3, Niti Goel4, Michael Farwell5 and Steven Greenberg6, 1Department of Neurology, University of Pennsylvania, Philadelphia, PA, 2ImaginAb, Inglewood, CA, 3ImaginAb, Inc, Inglewood, CA, 4Abcuro, Inc., Newton,, MA, 5Department of Radiology, University of Pennsylvania, Philadelphia, PA, 6Brigham and Women's Hospital Department of Neurology, Boston, MA

    Background/Purpose: Inclusion body myositis (IBM) is a slowly progressive autoimmune skeletal muscle disease for which no effective pharmacological therapy is available. A prominent feature of…
  • Abstract Number: 1474 • ACR Convergence 2021

    Automatic Detection of Bone Marrow Lesions from Knee MRI Data from the OAI Study

    Shen Liu1, Xiaoxiao Sun1, Frank Roemer2, Erin Ashbeck3, Edward Bedrick1, Zong-Ming Li1, Ali Guermazi4 and Kent Kwoh1, 1University of Arizona, Tucson, AZ, 2Friedrich-Alexander University Erlangen-Nurnberg, Erlangen, Germany, 3University of Arizona Arthritis Center, Tucson, AZ, 4Boston University, Boston, MA

    Background/Purpose: Subchondral bone marrow lesions (BMLs) are associated with symptoms and structural progression of knee OA. BMLs are characterized by diffuse hyperintensity on fat suppressed…
  • Abstract Number: 0168 • ACR Convergence 2021

    A Crowdsourcing Approach to Develop Machine Learning Models to Quantify Radiographic Joint Damage in Rheumatoid Arthritis

    Dongmei Sun1, Robert Allaway2, Jelai Wang1, Verena Chung2, Thomas Yu2, Isaac Dimitrovsky3, Lars Ericson4, Yuanfang Guan5, Ariel Israel6, Hongyang Li5, Michael Mason7, Alex Olar8, Balint Pataki8, Stephanie Ledbetter1, RA2 DREAM Challenge Community9, Gustavo Stolovitzky10, Justin Guinney2, Percio Gulko11, Mason Frazier1, James Costello12, Jake Chen1 and S. Louis Bridges, Jr.13, 1University of Alabama at Birmingham, Birmingham, AL, 2Sage Bionetworks, Seattle, WA, 3Self-employed, New York, NY, 4Catskills Research, Charlotte, NC, 5University of Michigan, Ann Arbor, MI, 6Hebrew University, Jerusalem, Israel, 7BMS, Seattle, WA, 8Eotvos Lorand University, Budapest, Hungary, 9RA2 DREAM Challenge Community, New York, NY, 10IBM, New York, NY, 11Icahn School of Medicine at Mount Sinai, New York, NY, 12University of Colorado Anschutz Medical Campus, Denver, CO, 13Hospital for Special Surgery, New York, NY

    Background/Purpose: Rheumatoid arthritis (RA) is a common chronic autoimmune disease characterized by inflammation of the synovium, leading to joint space narrowing and osseous erosions. The…
  • Abstract Number: 0772 • ACR Convergence 2021

    Pediatric Craniofacial Scleroderma: Assessing Handheld 3D Stereophotogrammetric Imaging Feasibility and Reliability

    Daniel Glaser1, Kaila Schollaert-Fitch2, Christopher Liu1, Jesse Goldstein1 and Kathryn Torok2, 1UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Craniofacial scleroderma (Cf-LS), also known as Parry-Romberg Syndrome or scleroderma en coup de sabre, is a subtype of localized scleroderma (morphea). Diagnosis and monitoring…
  • Abstract Number: 1503 • ACR Convergence 2021

    Putting the Pieces on the Board: Mapping SLE Nephritis Biopsies from the Accelerating Medicines Project Using High-Density Immunofluorescence Imaging

    Craig Smuda1, Anna Eichinger2, Robert Clancy2, Jill Buyon3 and Boris Reizis4, 1NYU Grossman School of Medic ine, New York, NY, 2NYU Grossman School of Medicine, New York, NY, 3NYU School of Medicine, New York, NY, 4New York University Grossman School of Medicine, New York, NY

    Background/Purpose: The Accelerating Medicines Project (AMP) has enabled significant increases in understanding of SLE nephritis pathology, providing a profile of dozens of leukocyte subsets within…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 43
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology